OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The international consensus classification of eosinophilic disorders and systemic mastocytosis
Sa A. Wang, Attilio Orazi, Jason Gotlib, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 8, pp. 1286-1306
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Neutrophilic and eosinophilic dermatoses associated with hematological malignancy
Carlo Alberto Maronese, Federica Derlino, Chiara Moltrasio, et al.
Frontiers in Medicine (2024) Vol. 10
Open Access | Times Cited: 10

Involvement of the JAKSTAT pathway in the molecular landscape of tyrosine kinase fusion‐negative hypereosinophilic syndromes: A nationwide CEREO study
Matthieu Groh, Laurène Fenwarth, Mathilde Labro, et al.
American Journal of Hematology (2024) Vol. 99, Iss. 6, pp. 1108-1118
Closed Access | Times Cited: 5

A case of myeloproliferative neoplasm with eosinophilia associated with PCM1-JAK2 rearrangement
Wen Zhou, Xiaojia Guo, Yang Liu, et al.
Case Reports in Oncology (2025) Vol. 18, Iss. 1, pp. 190-197
Closed Access

An Approach to the Bone Marrow Workup and Diagnosis of Eosinophilia and Mast Cell Disorders
Kaaren K. Reichard, Tracy I. George, Daniel A. Arber
Advances in Anatomic Pathology (2025)
Closed Access

Hypereosinophilic Syndrome
Robert Gniadecki, Minakshi Taparia, Jean Deschênes, et al.
(2025), pp. 159-165
Closed Access

Identification of rare recurrent FNBP1::JAK2 fusion in myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions
Hong Yao, Qian Wang, Man Wang, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2025), pp. 1-4
Closed Access

Biologic Agents in Idiopathic Hypereosinophilic Syndrome
Ουρανία Παπαϊωάννου, Fotios Sampsonas, Panagiota Tsiri, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 543-543
Open Access

Introduction to a How I Treat series on myeloproliferative neoplasms
Jason Gotlib
Blood (2025) Vol. 145, Iss. 16, pp. 1707-1709
Closed Access

Mastocytosis
Cem Akin, Michel Arock, Melody C. Carter, et al.
Nature Reviews Disease Primers (2025) Vol. 11, Iss. 1
Closed Access

Harmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNM
Peter Valent, Karin Hartmann, Gregor Hoermann, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 12, pp. 3250-3260.e5
Open Access | Times Cited: 3

Prognostic factors of idiopathic hypereosinophilic syndrome: A nationwide survey in Japan
Akira Honda, Yasutaka Masuda, Yu Oyama, et al.
British Journal of Haematology (2024) Vol. 205, Iss. 3, pp. 967-977
Open Access | Times Cited: 2

Phase II trial of imatinib mesylate in patients with PDGFRA/B‐negative hypereosinophilic syndrome
Dong Hyun Kim, Seokhyeon Kim, Seonyang Park, et al.
British Journal of Haematology (2024)
Open Access | Times Cited: 2

Reappraisal of mast cell leukemia based on a single institution review of 16 cases: Mast cell morphology determines clinical outcome
Animesh Pardanani, Ayalew Tefferi, Aref Al‐Kali, et al.
American Journal of Hematology (2023) Vol. 99, Iss. 1
Open Access | Times Cited: 4

Cardiac Mechanics and Valvular and Vascular Abnormalities in Hypereosinophilic Syndrome
Attila Nemes
Journal of Clinical Medicine (2024) Vol. 13, Iss. 5, pp. 1403-1403
Open Access | Times Cited: 1

Review of Peripheral Blood Eosinophilia: Workup and Differential Diagnosis
Michael Dennis Weaver, B. Glaß, Chance J Aplanalp, et al.
Hemato (2024) Vol. 5, Iss. 1, pp. 81-108
Open Access | Times Cited: 1

Clinical and biological characteristics associated with bronchial or pulmonary abnormalities on chest CT imaging in patients with systemic mastocytosis
Raphael Vallière, C. Bulaï Livideanu, Thomas Villeneuve, et al.
Clinical and Translational Allergy (2024) Vol. 14, Iss. 8
Open Access | Times Cited: 1

Characteristics and outcomes associated with CD2 and CD25 expression on bone marrow mast cells in patients with systemic mastocytosis
Julien Rossignol, Sophie Georgin‐Lavialle, Danielle Canioni, et al.
Haematologica (2024)
Open Access | Times Cited: 1

Mast cell cytomorphology and treatment outcome in mast cell leukemia
Ayalew Tefferi, Animesh Pardanani, Aref Al‐Kali, et al.
American Journal of Hematology (2023) Vol. 99, Iss. 1
Open Access | Times Cited: 3

Granularity in disease classification impacts survival prediction in advanced systemic mastocytosis: A single institution study of 329 informative cases
Ayalew Tefferi, Maymona Abdelmagid, Aref Al‐Kali, et al.
American Journal of Hematology (2023) Vol. 99, Iss. 1, pp. 21-27
Closed Access | Times Cited: 3

Case Report: A novel FGFR1 fusion in acute B-lymphoblastic leukemia identified by RNA sequencing
Zhibo Zhang, Yiyan Zhu, Zheng Wang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3

Advanced systemic mastocytosis—Revised classification, new drugs and how we treat
Animesh Pardanani, Kaaren K. Reichard, Ayalew Tefferi
British Journal of Haematology (2023) Vol. 204, Iss. 2, pp. 402-414
Closed Access | Times Cited: 2

[Guideline of the diagnosis and treatment of eosinophilic disorders (2024)].

PubMed (2024) Vol. 45, Iss. 1, pp. 1-7
Closed Access

Diagnosis of systemic mastocytosis with cryptic deletion of TET2 and DNMT3A resulting from unbalanced translocation
Signy Chow, Stephanie J. Lee, August Lin, et al.
British Journal of Haematology (2024) Vol. 205, Iss. 3, pp. 961-966
Open Access

Page 1 - Next Page

Scroll to top